1. Gilden D, Nagel MA, Cohrs RJ. Varicella-zoster. Handb Clin Neurol 2014;123:265-83.
2. Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nat Rev Dis Primers 2015;1:15016.
3. Andrei G, Snoeck R. Advances and Perspectives in the Management of Varicella-Zoster Virus Infections. Molecules 2021;26(4):1132.
4. Kennedy PGE, Gershon AA. Clinical Features of Varicella-Zoster Virus Infection. Viruses 2018;10(11):609.
5. Newman AM, Jhaveri R. Myths and Misconceptions: Varicella-Zoster Virus Exposure, Infection Risks, Complications, and Treatments. Clin Ther 2019;41(9):1816-1822.
6. Schmader K. Herpes Zoster. Ann Intern Med 2018;169(3):ITC19-ITC31.
7. Gabutti G, Bolognesi N, Sandri F, Florescu C, Stefanati A. Varicella zoster virus vaccines: an update. Immunotargets Ther 2019;8:15-28.
8. Levin MJ, Weinberg A, Schmid DS. Herpes Simplex Virus and Varicella-Zoster Virus. Microbiol Spectr 2016;4(3).
9. Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol 2014;12(3):197-210.
10. Warren-Gash C, Forbes H, Breuer J. Varicella and herpes zoster vaccine development: lessons learned. Expert Rev Vaccines 2017;16(12):1191-1201.
11. Lee SJ, Kim H, Hong K, J Nam J. Immune Responses to Varicella Zoster Virus and Effective Vaccines.J Bacteriol Virol 2021; 51(3): 103-111.
12. Tommasi C, Breuer J. The Biology of Varicella-Zoster Virus Replication in the Skin. Viruses 2022;14(5):982.
13. Oliver SL, Zhou M, Arvin AM. Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis. Biochem Soc Trans 2020;48(6):2415-2435.
14. Laing KJ, Ouwendijk WJD, Koelle DM, Verjans GMGM. Immunobiology of Varicella-Zoster Virus Infection. J Infect Dis 2018;218(suppl_2):S68-S74.
15. Sauerbrei A. Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections. Eur J Clin Microbiol Infect Dis 2016; 35:723–734.
16. Tayyar R, Ho D. Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients. Viruses 2023;15(2):439.
17. Mehrmal S, Mojica R, Guo AM, Missall TA. Diagnostic Methods and Management Strategies of Herpes Simplex and Herpes Zoster Infections. Clin Geriatr Med 2024;40(1):147-175.
18. Arnold N, Messaoudi I. Herpes zoster and the search for an effective vaccine. Clin Exp Immunol 2017;187(1):82-92.
19. Patil A, Goldust M, Wollina U. Herpes zoster: A Review of Clinical Manifestations and Management. Viruses 2022;14(2):192.
20. Kennedy PGE. The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation. Viruses 2023;15(8):1663.
21. Singh S, Sharma A, Rahman MM, Kasniya G, Maheshwari A, Boppana SB. Congenital and Perinatal Varicella Infections. Newborn (Clarksville) 2022;1(3):278-286.
22. Dollard S, Chen MH, Lindstrom S, Marin M, Rota PA. Diagnostic and Immunologic Testing for Varicella in the Era of High-Impact Varicella Vaccination: An Evolving Problem. J Infect Dis
2022;226(Suppl 4):S450-S455.
23. Pan D, Wang W, Cheng T. Current Methods for the Detection of Antibodies of Varicella-Zoster Virus: A Review. Microorganisms 2023;11(2):519.
24. Park R, Hwang JY, Lee KI, Namkoong S, Choi SK, Park S, et al. Measurement of antibodies to varicella-zoster virus using a virus-free fluorescent-antibody-to-membrane-antigen (FAMA) test.
J Microbiol Biotechnol 2015;25(2):268-73.
25. Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines 2014;2(2):39-55.
26. Wang L, Zhu L, Zhu H. Efficacy of varicella (VZV) vaccination: an update for the clinician. Ther Adv Vaccines 2016;4(1-2):20-31.
27. Soysal A, Gönüllü E, Yıldız İ, Karaböcüoğlu M. Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study. Hum
Vaccin Immunother 2021;17(3):731-737.
28. Hekimoğlu CH, Özbek ÖA, Emek M, Öktem MA, Köroğlu G, Sertel M, et al. Seroprevalence and social determinants of varicella in Turkey. East Mediterr Health J 2018;24(3):295-301.
29. Harbecke R, Cohen JI, Oxman MN. Herpes Zoster Vaccines. J Infect Dis 2021 Se;224(12 Suppl 2):S429-S442.
30. Lachiewicz AM, Srinivas ML. Varicella-zoster virus post-exposure management and prophylaxis: A review. Prev Med Rep 2019;16:101016.
31. Gans H, Chemaly RF. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access
program. BMC Infect Dis 2021;21(1):46